Skip to main content
. Author manuscript; available in PMC: 2011 Nov 2.
Published in final edited form as: Angew Chem Int Ed Engl. 2010 Nov 2;49(45):8484–8488. doi: 10.1002/anie.201004026

Figure 1.

Figure 1

Schematic showing myosin V walking on actin filaments and structures of ‘privileged’ scaffold (bold)-based compounds as potential inhibitors (X=NH or CH2; R1–3 are various aliphatic or aromatic groups).